Cristina Valero1, Ian Ganly1, Jatin P Shah1,2. 1. Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. 2. Department of Oncology, Radiotherapy and Plastic Surgery, Sechenov University, Moscow, Russia.
Abstract
BACKGROUND: We aimed to review our experience and the changing trends in the management of head and neck paragangliomas (HNPG) over the last three decades. METHODS: We retrospectively reviewed 103 patients with HNPG treated at our center (1986-2017). We included patients treated with surgery, radiotherapy, and patients maintained under active surveillance. RESULTS: Of the surgically treated patients (n = 79), 20% (12/59) of the carotid body tumors (CBT) had a cranial nerve deficit as sequela compared to 95% (19/20) of the non-CBT. Radiotherapy controlled growth in all tumors treated with this modality (n = 10). Of the initially observed patients, 70% (14/20) remained stable and did not require additional treatment. Stratifying by decades, there was a progressive increase in patients initially attempted to be observed and a decrease in upfront surgery. No deaths attributable to the HNPG were encountered. CONCLUSIONS: Surgery is an effective treatment for CBT. Nonsurgical treatment should be considered for non-CBT.
BACKGROUND: We aimed to review our experience and the changing trends in the management of head and neck paragangliomas (HNPG) over the last three decades. METHODS: We retrospectively reviewed 103 patients with HNPG treated at our center (1986-2017). We included patients treated with surgery, radiotherapy, and patients maintained under active surveillance. RESULTS: Of the surgically treated patients (n = 79), 20% (12/59) of the carotid body tumors (CBT) had a cranial nerve deficit as sequela compared to 95% (19/20) of the non-CBT. Radiotherapy controlled growth in all tumors treated with this modality (n = 10). Of the initially observed patients, 70% (14/20) remained stable and did not require additional treatment. Stratifying by decades, there was a progressive increase in patients initially attempted to be observed and a decrease in upfront surgery. No deaths attributable to the HNPG were encountered. CONCLUSIONS: Surgery is an effective treatment for CBT. Nonsurgical treatment should be considered for non-CBT.
Authors: Adam H Power; Thomas C Bower; Jan Kasperbauer; Michael J Link; Gustavo Oderich; Harry Cloft; William F Young; Peter Gloviczki Journal: J Vasc Surg Date: 2012-06-23 Impact factor: 4.268
Authors: William M Mendenhall; Christopher G Morris; Robert J Amdur; Kathryn E Hitchcock; Natalie L Silver; Peter T Dziegielewski Journal: Head Neck Date: 2019-02-19 Impact factor: 3.147
Authors: Mohamed A Elshaikh; Ashraf S Mahmoud-Ahmed; Sam E Kinney; Benjamin G Wood; Joung H Lee; Gene H Barnett; John H Suh Journal: Int J Radiat Oncol Biol Phys Date: 2002-03-15 Impact factor: 7.038
Authors: Carlos Suárez; Juan P Rodrigo; William M Mendenhall; Marc Hamoir; Carl E Silver; Vincent Grégoire; Primož Strojan; Hartmut P H Neumann; Rupert Obholzer; Christian Offergeld; Johannes A Langendijk; Alessandra Rinaldo; Alfio Ferlito Journal: Eur Arch Otorhinolaryngol Date: 2013-02-19 Impact factor: 2.503
Authors: Russell W Hinerman; Robert J Amdur; Christopher G Morris; Jessica Kirwan; William M Mendenhall Journal: Head Neck Date: 2008-11 Impact factor: 3.147
Authors: Roberto G Aru; Rony K Aouad; Justin F Fraser; Amanda M Romesberg; Kevin W Hatton; Sam C Tyagi Journal: J Vasc Surg Cases Innov Tech Date: 2021-05-20